Respira Therapeutics
Albuquerque
About Respira Therapeutics
Respira is a product development-stage company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs. The company realized seed capitalization from the Cottonwood Technology Fund on October 2010 for scientific development and commercialization of its patent pending technology for passive dry powder inhalers (DPI), consisting of a unique drug delivery engine with a novel, patent pending mechanism of action for lung delivery and therapy. Clinical proof-of-principle has been achieved. Respira Therapeutics DPIs have demonstrated "best-in-class" drug dispersion performance, and are uniquely positioned to replace currently marketed devices and to broaden inhaled therapies to drug classes/disease indications in high value therapeutic areas by virtue of superior performance and payload outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2015)
- Website: respiratherapeutics.com
- Phone: 5058201832
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/respira-therapeutics-2221855 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.